INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS INTEGRASE BY BIS-CATECHOLS

被引：78

作者：

LAFEMINA, RL ^{[1
]}

GRAHAM, PL ^{[1
]}

LEGROW, K ^{[1
]}

HASTINGS, JC ^{[1
]}

WOLFE, A ^{[1
]}

YOUNG, SD ^{[1
]}

EMINI, EA ^{[1
]}

HAZUDA, DJ ^{[1
]}

机构：

[1] MERCK SHARP & DOHME LTD, RES LABS, DEPT MED CHEM, W POINT, PA 19486 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1995年 / 39卷 / 02期

关键词：

D O I：

10.1128/AAC.39.2.320

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The human immunodeficiency virus type 1 (HIV-1) integrase protein is required for the productive infection of T-lymphoid cells in culture (R. L. LaFemina, C. L. Schneider, H. L. Robbins, P. L. Callahan, K. LeGrow, E. Roth, W. A. Schleif, and E. A. Emini, J. Virol, 66:7414-7419, 1992). This observation suggests that chemical inhibitors of integrase ay prevent the spread of HIV in infected individuals. In our search for such potential chemotherapeutic agents, we observed that beta-conidendrol inhibits both the sequence-dependent and sequence-independent endonucleolytic activities of integrase with comparable potencies in vitro (50% inhibitory concentration, 500 nM), Structurally related compounds tested for their abilities to inhibit integrase generated a limited structure-activity analysis which demonstrated that potency is associated with the bis-catechol structure: two pairs of adjacent hydroxyls on separate benzene rings. beta-Conidendrol did not inhibit several other endonucleases and/or phosphoryltransferases. Although beta-conidendrol was not effective in preventing HIV-1 infection in cell culture, the in vitro data demonstrate that it is possible to identify selective agents targeted against this essential HIV-1 function.

引用

页码：320 / 324

页数：5

共 44 条

[1] HIV-1 INTEGRASE - HIGH-LEVEL PRODUCTION AND SCREENING ASSAY FOR THE ENDONUCLEOLYTIC ACTIVITY [J].

BILLICH, A ;

SCHAUER, M ;

FRANK, S ;

ROSENWIRTH, B ;

BILLICH, S .

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (02) :113-119

[2] RETROVIRAL INTEGRATION - STRUCTURE OF THE INITIAL COVALENT PRODUCT AND ITS PRECURSOR, AND A ROLE FOR THE VIRAL IN PROTEIN [J].

BROWN, PO ;

BOWERMAN, B ;

VARMUS, HE ;

BISHOP, JM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2525-2529

[3]

BROWN PO, 1990, CURR TOP MICROBIOL, V157, P19

[4] ASSOCIATION OF INTEGRASE, MATRIX, AND REVERSE-TRANSCRIPTASE ANTIGENS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH VIRAL NUCLEIC-ACIDS FOLLOWING ACUTE INFECTION [J].

BUKRINSKY, MI ;

SHAROVA, N ;

MCDONALD, TL ;

PUSHKARSKAYA, T ;

TARPLEY, WG ;

STEVENSON, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :6125-6129

[5]

BURKE CJ, 1992, J BIOL CHEM, V267, P9639

[6] RETROVIRAL DNA INTEGRATION DIRECTED BY HIV INTEGRATION PROTEIN INVITRO [J].

BUSHMAN, FD ;

FUJIWARA, T ;

CRAIGIE, R .

SCIENCE, 1990, 249 (4976) :1555-1558

[7] ACTIVITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INTEGRATION PROTEIN INVITRO - SPECIFIC CLEAVAGE AND INTEGRATION OF HIV DNA [J].

BUSHMAN, FD ;

CRAIGIE, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1339-1343

[8] INHIBITORY EFFECT OF THE POLYANIONIC DRUG SURAMIN ON THE IN-VITRO HIV DNA INTEGRATION REACTION [J].

CARTEAU, S ;

MOUSCADET, JF ;

GOULAOUIC, H ;

SUBRA, F ;

AUCLAIR, C .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 305 (02) :606-610

[9] EFFECT OF TOPOISOMERASE INHIBITORS ON THE INVITRO HIV DNA INTEGRATION REACTION [J].

CARTEAU, S ;

MOUSCADET, JF ;

GOULAOUIC, H ;

SUBRA, F ;

AUCLAIR, C .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (03) :1409-1414

[10] THE IN PROTEIN OF MOLONEY MURINE LEUKEMIA-VIRUS PROCESSES THE VIRAL-DNA ENDS AND ACCOMPLISHES THEIR INTEGRATION INVITRO [J].

CRAIGIE, R ;

FUJIWARA, T ;

BUSHMAN, F .

CELL, 1990, 62 (04) :829-837

← 1 2 3 4 5 →